ANTIVIRAL DRUGS

New synthetic corticosteroids inhibit Epstein–Barr virus release.

Novel spiroandrostene-17,6'-[1,3,4]thiadiazines obtained by synthesis from 16β,17β-epoxy-17-isopregn-5-en-3β-ol-20-one and N-aryl-2-hydrazino-2-thioxoacetamide efficiently inhibited the release of Epstein–Barr virus from cells carrying the virus in culture.

 

ORDERS : Online

By Email: orders@capitalbiosciences.com

Technical Inquiries:

Please note: we take all technical inquiries by email. Email your questions to TechSupport and receive a detailed response within 24 hours.

Billing, Sales, Customer Support:                     1-240-240-2451

sign up for our Newsletter